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Abstract 
Background: The success of a reporting system of adverse drug reaction (ADR) depends on the 
knowledge, attitudes and practices of health care professionals. However, due to lack of knowledge 
and poor contribution by healthcare workers, ADR remains underreported. To improve safety, 
proper identification and ADR reporting is necessary. Objective: This study was carried out to 
determine knowledge, attitude and practices of ADR among physicians and pharmacists working 
in Pakistan and the factors which encourage and discourage effective reporting. Methods: A cross-
sectional study was conducted using a pretested questionnaire. Questionnaires were distributed 
among 333 physicians and 34 pharmacists with a 95.5% response rate. The Statistical Package for 
Social Science (SPSS) was used for data analysis. Results: Pharmacists have more knowledge 
regarding ADR compared to physicians (47.1% vs 13.8%, p < 0.001). Pharmacists have also 
positive attitude compared to physicians (97.1% vs. 76.3%, p < 0.001). No significant difference 
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was noticed in ADR practice by physicians and pharmacists (12.3% vs 11.8, p = 0.92). The 
seriousness of ADR was the main factor which encourages nearly all pharmacists to report, 
s seriousness of the reaction, the unusualness of reaction, the new drug 
involvement, and confidence in diagnosis were the factors which encourage them to report ADR.  
Conclusion: Overall, pharmacists had more knowledge and a positive attitude regarding ADR 
reporting compared to physicians, but practices of ADR reporting remained the same among both. 
Therefore, it is suggested that educational interventions along with training programs should be 
developed. 
 
Keywords: Adverse drugs reactions, Public health; Pharmacovigilance; health care systems; 
hospitals; ADR reporting. 
 
 Introduction 
Adverse drug reaction (ADR) is a major problem, occurring worldwide. Consequently, it is 
important to report every adverse drug reaction and many developing countries are making great 
efforts in order to develop strong ADR reporting systems (1). ADR is one of the most common 
cause of morbidity and mortality around the world (2). Yet reducing the incidence associated with 
ADR is a great challenge for all health care professionals. ADRs have a great impact on the health 
of people by creating an economic burden on health care systems and society (3). For an efficient 
ADR reporting system, adequate knowledge and positive attitudes are important in healthcare 
professionals, as this could lead to the detection, assessment, prevention and reporting of ADR. 
An effective ADR reporting system is also needed for the development of effective 
pharmacovigilance programs (4, 5). Yet despite the progress in ADR reporting, the burden of ADR 
on public health remains significant, as pharmacoeconomic studies show that a considerable 
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proportion of the health budget is still spent in treating ADR (6). The number of deaths associated 
with ADR is also significant, as approximately 100,000 people have died due to adverse drug 
events alone (7)(8-12). Yet almost 30 80% of ADR are preventable, which presents an opportunity 
for the development of robust reporting programs to enhance patient care and reduce hospital 
admissions (13).  
 
In Pakistan approximately 10,000 public health care facilities are present, yet the private health 
care sector serves 70% of the population (14). Still, no organized system of disease surveillance, 
proper health policies or system research is currently present (15). Nevertheless, studies show that 
irrational drug use and mortality and morbidity associated with ADR is very common in Pakistan 
and this highlights the importance of improving pharmacovigilance in Pakistan (15). Whilst a 
National Health Policy (NHP) is present in Pakistan (16), pharmacovigilance is not a part of the 
National drug policy (NDP) (17). However, the National Pharmacovigilance centre is present (18), 
and for reporting of ADR, an official form is used and accessed via the Ministry of Health website 
(19). The NDP states that a monitoring centre for ADR will be established, post-marketing 
surveillance of new drugs will be done and monitoring of ADR will also be carried out (20). Yet 
in Pakistan, practices associated with pharmacovigilance are currently poor, and underreporting of 
ADR remains throughout the world (2, 21-23). Both physicians and pharmacists have an important 
role in improving the number and quality of ADR report (24-29). Therefore, the aim of the present 
study is to compare the knowledge, attitude and practice regarding ADR between physicians and 
pharmacists to identify reasons for under-reporting and the steps that are needed to increase ADR 
reporting in Pakistan. 
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 Materials and Methods 
2.1 Study Setting and Design 
A cross-sectional study was conducted in the capital city of Pakistan among physicians and 
pharmacists. In this study, 367 participants (333 physicians; 34 pharmacists) participated giving 
an overall response rate of 95.5%.  
2.2 Study Tool 
A questionnaire was developed after collecting information on the knowledge, attitude and 
practices of ADR reporting among physicians and pharmacists around the world. (25, 30-32).  The 
final form of the questionnaire consisted of 5 parts. Part one included 4 questions on  
demographic information, second part contains 9 questions to know  knowledge of 
ADR and pharmacovigilance, third part consisted of 4 questions to determine health  
attitude towards ADR reporting, fourth part had 9 questions which identify the practice of ADR in 
hospitals and fifth part of the questionnaire include 2 questions related to factors which encourage 
and discourage respondents from reporting ADR.  
2.3 Validity of Questionnaire 
The questionnaire was reviewed by 2 expert pharmacists present at the Quaid-i-Azam University, 
Pakistan, they checked the questions clarity, relevance and consistencies. After this, a pilot study 
was conducted by distributing the questionnaire to 30 physicians and 10 pharmacists of four 
different hospitals to assess questionnaire validity. Slight modifications were carried out and 
cronbach alpha came out to be 0.72, after that questionnaire was finalised. Data collected during 
the pilot study was not included in the results reported below. 
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2.4 Sample Recruitment and Data Collection 
Private, governmental, teaching and specialist hospital sites in Islamabad were selected randomly, 
respondents were then selected via convenience sampling. Surveys were sent to a variety of local 
hospitals, and the respondents were directly contacted via their department. The respondents were 
briefed about the objectives of the study and invited to complete the questionnaire. Some 
questionnaires were left, and then collected after 1-2 days. Some of the questionnaires with 
attached informed consent were distributed via hospital directors and were collected after 2 weeks. 
2.5 Data Analysis 
Quantitative data were analysed by using SPSS version 21. The data was coded and then verified 
systematically for any errors. Descriptive and inferential statistics were carried out. For 
quantitative variables arithmetic mean and standard deviation and for qualitative variables, 
percentages and frequencies were calculated. Comparison between knowledge, attitude and 
practice data obtained from physicians and pharmacists was done by using Chi-square test or 




In this study, questionnaires were completed by 333 physicians and 34 pharmacists through direct 
correspondence, email and via hospital directors giving an overall response rate of 95.5%. Among 
respondents, 64.3% physicians and 23.5% pharmacists were from the public hospital whereas 
35.7% physicians and 76.5 pharmacists were from private hospitals (p < 0.00). The average age of 
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physicians and pharmacists was 28.6± 6.9 and 25.4 ±1.9 respectively. Demographics details are 
shown in Table 1. 
 
Table 1: Demographic characteristics of respondents. 
Demographic features Categories Physicians Pharmacist p value 
Age  Mean age:  28.6 ± 
6.9 

























3.2 Description of Knowledge Regarding Pharmacovigilance and ADR 
Several items were added to 
knowledge. Results showed that difference between pharmacist and physician knowledge 
regarding every aspect of ADR and pharmacovigilance varied from question to question. 
Significantly pharmacists have better knowledge regarding correct definition of 
pharmacovigilance (61.8% vs 13.2%, p < 0.001), correct definition of ADR (61.8% vs 31.8%, p < 
0.001) and type of ADR (73.5% vs 30.6%, p < 0.001). Pharmacists knew significantly more than 
physicians about International ADR reporting center (52.9% vs 20.7%, p < 0.001), National 
pharmacovigilance centre (47.1% vs 17.4%) and drugs that are banned due to ADR (61.85% vs 
7
20.4%). On the other hand, none of the pharmacists was aware of WHO online database whereas 
19.5% physicians have knowledge about it (p <0.001) (Error! Reference source not found.). 





n = 333 
Pharmacists 
 





Yes= n (%) 
 
44 (13.2) 21 (61.8) <0.001 
No= n (%) 
 
289 (86.8) 13 (38.2) 
Know about ADR definition Yes= n (%) 
 
106 (31.8) 21 (61.8) <0.001 
No= n (%) 
 
227 (68.2) 13 (38.2) 
Know about types of ADR Yes= n (%) 
 
102 (30.6) 25 (73.5) <0.001 
No= n (%) 
 
231(69.4) 9 (26.5) 
Know about international 
canter for ADR monitoring 
Yes= n (%) 
 
69 (20.7) 18 (52.9) <0.001 
No= n (%) 
 
264 (79.3) 16 (47.1) 
Aware of the drug that has 
been banned in the world 
Yes= n (%) 
 
68 (20.4) 21 (61.8) <0.001 
No= n (%) 
 
265 (79.6) 13 (38.2) 
Know about the ADR 
reporting centre in Pakistan 
Yes= n (%) 
 
58 (17.4) 16 (47.1) <0.001 
No= n (%) 
 
275 (82.6) 18 (52.9) 
Shared information about 
ADR with others 
Yes= n (%) 
 
38 (11.4) 23 (67.6) <0.001 
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No= n (%) 
 
294 (88.6) 11 (32.4) 
Agree that side effects like a 
headache, nausea and 
vomiting should be reported 
Yes= n (%) 
 
131 (39.3) 4 (11.8) 0.006 
No= n (%) 
 
202 (60.7) 30 (88.2) 
Know about WHO online 
database for reporting ADR 
Yes= n (%) 
 
65 (19.5) 0 (0.0) <0.001 
No= n (%) 
 
268 (80.5) 34 (100) 
 
3.3 Attitudes about ADRs Reporting 
No significant difference between physicians and  attitude was seen in terms of 
believing that ADR reporting is necessary (96.7% vs 97.1%) and ADR reporting should be made 
mandatory (97.2% vs 100%). However, physicians have significantly stronger belief than 
pharmacists that ADR reporting increase patient safety (97.8% vs 85.2%, p < 0.001). Pharmacists 
significantly outnumbered physicians in believing that ADR reporting is not time consuming 
(61.7% vs 26.4%, p < 0.001) (Table 3). 
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Table 3: The attitude of health care professionals towards ADR reporting. 




Is ADR reporting necessary?  
  
 
Yes = n (%) 
 
322 (96.7) 33 (97) 0.31 
       No = n (%) 11 (3.3) 1(2.9) 
ADR reporting should be 
mandatory 
 
Yes = n (%) 
 
324 (97.2) 34 (100) 0.77 
No = n (%) 9 (2.7) 0 (0.0) 
ADR reporting increase patient 
safety 
 
Yes = n (%) 
 
326 (97.8) 29 (85.2) <0.001 
No = n (%) 7 (2.1) 5 (14.7) 
ADR is time consuming 
 
Yes = n (%) 245 (73.5) 13 (38.2) <0.001 
No = n (%) 
 
88 (26.4) 21 (61.7) 
 
3.4 ADR Reporting Practice  
Among the respondents, 33% physicians and 35.3% pharmacists stated that at their workplace 
ADR reporting system is present. 34.2% physicians and 23.5% pharmacists have free access to 
reporting forms of ADR. Significant difference was noticed in the number of ADR respondents 
encountered per week, 51.4% physicians and 85.3% pharmacists encounter 0 5 ADR per week, 
32.1% physicians and 14.7% pharmacists encounter 6 10 ADR per week whereas 16.5% 
physicians encounter more than 10 ADR per week whereas none of the pharmacists encounters 
more than 10 ADR per week (p < 0.001). Among respondents, 12.3% physicians and 5.9% 
pharmacists stated that they have reported ADR which they encountered in their daily practice and 
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among those who have reported only 1.2% physicians have reported to the correct place whereas 
none of the pharmacists has reported to the correct place.  
 
Among ADR which were reported by physicians 58.5% were severe in nature, 17.8% were 
moderate and 9.2% were mild in nature. Whereas pharmacists stated that they have reported only 
those ADR which were severe in nature (p < 0.001). Among respondents, 42% physicians and 
67.6% pharmacists stated that their workplace encourages them to report adverse drug reaction (p 
< 0.001). 40.8% physician and 73.5% pharmacist stated that their work place provides information 
regarding ADR (p < 0.001). 14.4% physicians stated that they received training on ADR whereas 
0% pharmacists have ever trained on ADR. Significant difference (p < 0.001) was noticed in the 
methods which physicians and pharmacists prefer to report ADR; direct contact (59.8% vs 85.3%), 
email/website (24% vs 14.7%) and telephone (12% vs 0%) (Table 4) 





n = 333 
Pharmacists 
 
n = 34 
p value 
Is there any ADR reporting 
system present at your 
workplace? 
Yes = n (%) 
 
110 (33.0) 12 (35.3) 0.05 
No = n (%) 
 
174 (52.3) 22 (64.7) 
 49 (14.7) 0 (0.0) 
Do you have free access to 
ADR reporting forms? 
Yes = n (%) 
 
114 (34.2) 8 (23.5) 0.2 
No = n (%) 
 
219 (65.8) 26 (76.5) 
0  5 / week 171 (51.4) 29 (85.3) <0.001 
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How many ADRs per week 
do you encounter in your 
practice? 
6  10 / week 107 (32.1) 5 (14.7) 
More than 10 / 
week 
55 (16.5) 0 (0) 
Have you ever reported an 
ADR 
Yes = n (%) 
 
41(12.3) 2 (5.9) 0.4 
No = n (%) 
 
292 (87.7) 32 (94.1) 
Where have you reported? An ADR reporting 
centre 




8 (2.4) 15 (44.1) 
Head of your 
department 
312 (93.77) 6 (17.6) 
Ministry of health 4 (1.2) 5(14.8) 
The adverse drug reaction 
which you have reported 
were 
Severe 195 (58.5) 34 (100) <0.001 
Moderate 
 
31 (9.2) 0 (0.0) 
Mild 59 (17.8) 0 (0.0) 
All of above 48 (14.5) 0 (0.0) 
Which method would you 
prefer to send ADR 




199 (59.8) 29 (85.3) 0.01 
Post 14 (4.2) 0 (0.0) 
Telephone 
 
40 (12.0) 0 (0.0) 
Email/ websites 
 
80 (24.0) 5 (14.7) 
Yes = n (%) 
 
140 (42.0) 23 (67.6) 0.004 
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Does your workplace 
encourage you to 
practice/report ADR? 
No= n (%) 
 
193 (58.0) 11 (32.4) 
Does your workplace 
provide information 
regarding ADR reporting 
Yes= n (%) 
 
136 (40.8) 25 (73.5) <0.001 
No= n (%) 
 
197 (59.2) 9 (26.5) 
Have you ever been trained 
on how to report ADR? 
Yes= n (%) 
 
48 (14.4) 0 (0.0) 0.007 
No= n (%) 
 
285 (85.6) 34 (100) 
 
3.5 Overall Knowledge, Attitude and Practice of Respondents Regarding ADR 
 There were 10 questions  knowledge. Score 1  was given to each right 
answer and score 0  was given to the wrong answer. The score of knowledge was calculated for 
each physician and pharmacist and then knowledge was categorised as good for score ranging (6-
10) and poor for score ranging (0-5). Pharmacists were found to be more knowledgeable 47.1 % 
(n=16) about ADR reporting than physicians 13.8% (n=46, p  = 0.001). There were four questions 
The attitude score was calculated for both physicians and pharmacists, on the basis of which 
attitude of respondents was categorised as positive for score ranging (6-5) and negative. The results 
revealed that pharmacists have more positive attitude towards ADR reporting 97.1 % (n=33) than 
physicians 76.3% (n=254, p = 0.005). The practice of ADR was determined by finding an overall 
mean practice score of respondents. Score 1  was given to good practice and score 0  was 
given to poor practice. No significant difference was observed in practice of ADR reporting 























Fig. 1. Overall knowledge, Attitude and practice of respondents regarding ADR. 
3.6 Factors which Encourage and Discourage Health Care Professionals to 
Report ADR 
 As shown in Fig.2 nearly all pharmacists 94.1% (n=32) stated that the seriousness of reaction 
encourages them to report ADR. Whereas among doctor  seriousness of reaction 60.7% (n=202), 
unusualness of reaction 13.8% (n=46), the involvement of new drug 9.3% (n=31), confidence in 
the diagnosis of reaction 9.9% (n=33) were the main factors which encourage them to report ADR 
















Fig. 2. Factors which encourage physicians and pharmacists to report ADR. 
 
Factors which discourage pharmacists to report ADR include not knowing where and how to report 
ADR, lack of access to ADR reporting form, patient confidentiality issues and legal liability issues 
73.5% (n=25). Among physicians 22.2% (n=74) stated that they do not know how to report ADR, 
9.9% (n=33) do not know where to report ADR, 13.5% (n=45) think that managing patient is more 
important and 12.9% (n=43) physicians do not consider it important to report ADR (Fig.3). 
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Fig. 3.  Factors which discourage physicians and pharmacists to report ADR. 
3.7 Association of ADR Knowledge with Attitude and Practice 
It can be seen in Fig. 4, that significant association was present between  knowledge 
and attitude (p = < 0.001). Those respondents who have a good knowledge regarding ADR 
reporting have shown more positive attitude of 91.9% as compared to those who had poor 
knowledge 75.5%.  No significant association was found between knowledge and practice of ADR 
reporting. Among those who have good knowledge, 14.5% were practising ADR reporting 































Fig. 4. Association of knowledge of ADR with attitude and practice. 
3.8 How could ADR Reporting be Increased? 
Both physicians and pharmacists were asked how reporting of adverse drug reaction can be 
increased (open question) and different responses were given. Pharmacists broadly stated that 
education and training regarding ADR reporting should be conducted at regular intervals, ADR 
forms should be made freely available in hospitals, participation on ward rounds, development of 
local pharmacovigilance unit in hospital, periodic meeting of pharmacists with physicians, nurses 
and other health care workers are factors which could increase ADR reporting. According to 
physicians, reporting can be increased by education and training programs and by making it 
mandatory for all health professionals. The majority of responses given by physicians stated that 
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the procedure to report ADR should be made simple. Few stated that financial compensation 
should be provided. 
 Discussion 
This study was conducted to determine the knowledge, attitude and practices of ADR reporting 
among physicians and pharmacists working in secondary and tertiary hospitals of Pakistan. ADR 
underreporting is still related to poor ADR knowledge (33-35). Yet results presented here showed 
that pharmacists have generally good knowledge compared to physicians. These results reflect 
those reported by a similar survey conducted in Kuwait, which also showed that pharmacists had 
a good knowledge regarding ADR (36), and those from comparable Middle East countries  (37, 
38). Moreover, the current study showed that physicians have poor ADR knowledge. This finding 
is comparable to those unearthed in Canada, Nigeria, Malaysia, France, Italy and India where 
physicians have also been shown to have inadequate ADR  knowledge (39-43). In contrast, one 
study conducted in Nepal demonstrated that physicians actually had better ADR knowledge 
compared to pharmacists (26).  
 
Very few pharmacists were present in this study. One of the greater challenge pharmacists are 
facing is the less availability of jobs in hospital and acceptance by physicians (44). Another study 
related to ADR conducted in Saudi Arabia similarly presented a low ratio of physicians to 
pharmacists (148 physicians and 37 pharmacists respectively (45). In countries like Malaysia, there 
is also an acute shortage of pharmacists (46), and in Ghana only 619 pharmacists are present for 
2.9 million people (47). In Pakistan 8102 pharmacists are present, but only 15% are engaged in a 
clinical setting (48). 
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One unique finding of this study was that pharmacists in Pakistan who knew about PV definition 
(61.8%) were also aware of ADR definition (61.8%) as well as about drug which were banned due 
to ADR in the world (61.8%). These results reflect those of other published literature from Kuwait, 
Saudi Arabia, Oman and China (16, 36, 45, 49). Furthermore, this study revealed that none of the 
pharmacists in Pakistan was aware of formal ADR reporting centre in other countries and about 
WHO online database for reporting ADR but approximately half of the pharmacists were aware of 
national pharmacovigilance centre in Pakistan. In contrast majority of pharmacists are not aware 
of national pharmacovigilance centre in Kuwait and Jordan (36, 45, 50). This is a critical 
observation that despite the fact that both physicians and pharmacists had identified ADR during 
their course of practice only 12.3% physicians and 5.9% pharmacists have ever reported ADR. 
Furthermore, only a few were reported to the correct place. Similar results were found from other 
countries, where 32% physicians in Nigeria and 28.5% in China had reported ADR (51) (52). 
Moreover, only 14.3% pharmacists have ever reported ADR in Hong Kong (53), and a study 
conducted in Nepal showed only 33.7% reported ADR (26). In Qatar, 21.3% pharmacists have 
reported ADR whereas 21% in Istanbul and 14.6% in Northern China have ever reported ADR 
(32) (16). Underreporting of ADR is also seen among pharmacist in Rhode Island (54), Norway 
(55) and the United Kingdom (56). These findings reflect not only underreporting but also 
inappropriate reporting. Inadequate reporting is also seen in a study conducted in Saudi Arabia 
where 50% of ADR reported verbally by physicians and not to the proper place (57). 
 
Results from the current study showed that physicians have a more positive attitude as compare to 
physicians. An interesting finding was that 100% pharmacists agreed that reporting of ADR should 
be mandatory and nearly all of them agreed that it is necessary to report ADR and reporting 
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increase patient safety. The pharmacists positive attitude towards ADR reporting is also seen in 
Saudi Arabia (58), Turkey (32) and Oman (49). According to this study physicians also exhibit 
excellent attitude towards reporting of ADR. Yet despite the positive attitude of physicians, the 
majority of physicians stated that ADR is time-consuming. Other study conducted in Netherland 
reported that over 35% of physicians think that reporting ADR takes too much time (59). This 
might suggest that physicians have extra responsibilities, as Pakistan is a densely populated 
country which faces a shortage of physicians in hospitals, single physician have to attend 100 
patient in a couple of hours, on average physician give 1.8 minutes to one patient whereas in the 
USA physician spends 20 minutes and in Sweden, physician spend 22 minutes with one patient 
(60). 
 
One of the critical findings of this study was that approximately half of the pharmacists had good 
knowledge regarding ADR but only a few were practising ADR reporting. The reason for poor 
practising of ADR by pharmacists may be attributed to lack of training as none of the pharmacists 
in this study ever get trained on how to report ADR. In the present study, 100% pharmacists stated 
that they reported only those ADR which were severe. One study that was conducted in the United 
Kingdom stated that pharmacists are reluctant to report minor ADR as they were of opinion that 
reporting minor ADR would result in little impact (56). 
 
The reason cited by pharmacists and physicians for not reporting ADR include; lack of awareness 
regarding where and how to report, reporting ADR is not important, lack of access to reporting 
form, patient confidentiality and legal liability issues. The reason for underreporting by 
pharmacists in Norway includes lack of time, confidence and poor knowledge (55). Whereas lack 
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of time, lack of ADR form, a concern that reporting will generate extra work and concern about 
generating inappropriate report are the major reason which deters pharmacists to report ADR in 
the United Kingdom (56). In India, poor knowledge of where to report ADR, busy schedule and 
lack of incentives are the reasons which discourage physicians to report ADR (61).  
 
This study reveals that both physicians and pharmacists possess poor knowledge of ADR. Poor 
knowledge about ADR reporting is also seen in Jordan, Kuwait and Islamabad (36, 45, 50, 62). 
Moreover, 87.4% pharmacists in Hong Kong have poor ADR knowledge despite their positive 
attitude. According to Herdeiro et al., attitude has a strong influence on ADR reporting (63). An 
important finding revealed in this study was also the association between knowledge and attitude 
towards reporting of ADR whereas no significant association was seen between knowledge and 
practice of ADR reporting. Association was also present between attitude and practice of ADR 
reporting. These findings are consistent with other studies (64). This suggests that if ADR 
knowledge is improved among health care professionals then their attitude will also improve which 
in turn have a positive impact on ADR reporting. This is proved in another study that knowledge 
has a positive impact on the attitude which in turn influence ADR reporting behaviour in a positive 
manner (55). The low level of knowledge and poor practices seen in ADR reporting among 
physicians and pharmacists presented here suggests that there should be more advanced training 
and provisions designed and available to improve the reporting of ADR. Consequently, the authors 
of this study call for the development of such evidence-based education and training programs for 
physicians and pharmacists, as educational interventions play an important role in improving ADR 
reporting (26, 65-68).  Regular inspection and monitoring regarding the implementation of the 
ADR reporting system may also be required. As such, the Ministry of Health could usefully govern 
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and monitor the pharmacovigilance center by setting clear policies and legislation on what and 
how to report which may in turn improve the ADR reporting practices of pharmacist and 
physicians in Pakistan. 
 
 Conclusion 
The present study is the first to determine physicians and  knowledge, attitude and 
practice towards ADR reporting in Pakistan. Our results reveal that pharmacists in this setting had 
more knowledge as well as a more positive attitude regarding ADR reporting when compared to 
physicians, yet practices were found to be the same among both. ADR reporting may be improved 
through the development of educational training programs. Cooperation between physicians and 
pharmacists may also be of great importance, leading to improvements in the adverse drug reaction 
reporting system in Pakistan. The results presented here are not generalizable to other hospitals in 
Pakistan due to potential differences in the level of knowledge and practices in hospitals in other 
cities. Further studies are therefore recommended to strengthen the effectiveness of ADR reporting 
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